Industry CME Symposia and Learning Theaters

 

Industry CME Symposia and Learning Theaters

Industry Supported CME Symposia

Only CHEST Annual Meeting 2020 registered attendees will be able to access the Industry Supported CME Satellite Symposia.*

The majority of the CME symposia will be available to CHEST 2020 registrants until February 1, 2021.

To access:

  • Sign in to CHEST 2020
  • Select “Symposia”
  • Select “Access Now”
  • Search for the symposium you want to view
  • Press “Play” and enjoy!

11:15 am – 12:15 pm

Redefining the Diagnosis and Therapy of COPD: Lessons from COPDGene, GOLD Reports, and Precision Medicine
Provided by Integrity Continuing Education, Inc.
Supported by AstraZeneca

Management of Severe Asthma in 2020: An Immersive Virtual Simulation Program
Provided by MedscapeLIVE!
Supported by individual educational grants from Sanofi Genzyme and Regeneron Pharmaceuticals.

Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence
Provided by National Jewish Health
Supported by Insmed

When Is it PF-ILD? Diagnosis, Monitoring, and Treatment of a Complex Disease
Provided by Paradigm Medical Communications, LLC.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
Provided by PVI, PeerView Institute for Medical Education
Accredited by Medical Learning Institute, Inc.
This educational activity is supported by an educational grant from GlaxoSmithKline.

5:30 am – 6:30 pm

Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): The Importance of Early Diagnosis, Patient-centered Communication and Evidence-based Treatment
Provided by National Jewish Health
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

“Holding Court” in Pulmonary Hypertension: You, the “Jury”, Decide the Verdict to Better Outcomes
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Total CME.
Supported by Actelion Pharmaceuticals US, Inc.

Managing Influenza in At‐Risk Patients to Reduce Infection
This continuing medical education activity is provided by Vindico Medical Education.
This activity is supported by an educational grant from Genentech, Inc.

5:45 pm – 6:45 pm

Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype
Provided by National Jewish Health
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Management of Chronic Cough: Unmet Needs and Emerging Treatment Options
This continuing medical education activity is provided by Vindico Medical Education.
This continuing medical education activity is provided by Merck & Co., Inc.

4:45 pm – 5:45 pm

How Would You Treat These Patients? A Live Virtual Clinic in PAH
Provided by MedscapeLIVE!
Supported by individual educational grants from Actelion Pharmaceuticals, LTD and United Therapeutics Corporation.

 

Learning Theater Presentations

Learning Theater presentations* offer industry members an opportunity to present information on specific disease states, new treatments, and technologies to attendees in a virtual theater setting during CHEST Annual Meeting. 

The majority of the learning theater presentations will be available to CHEST 2020 registrants until February 1, 2021.

To access:

  • Sign in to CHEST 2020
  • Select “Learning Theater”
  • Select “Access Now”
  • Search for the presentation you want to view
  • Press “Play” and enjoy!

Clinical Insights in VTE: Treatment and Risk Reduction Through Prophylaxis
Sponsored by Janssen Pharmaceuticals, Inc.

Behold…BREZTRI AEROSPHERE™ (budesonide, glycopyrrolate, and formoterol fumarate)
Sponsored by AstraZeneca.

Management of Adults With Asthma or COPD With Inhaled Maintenance Treatment Options
Sponsored by GlaxoSmithKline.

The Current State of OFEV® (Nintedanib) Capsules: A Treatment Journey
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

Enhanced Performance of the Nodify XL2® Blood-Based Lung Nodule Test Through the Nodify Lung™ Integrated Testing Strategy
Sponsored by Biodesix Inc.

REPLACE (Riociguat rEplacing PDE-5i Therapy EvaLuated Against Continued PDE-5i thErapy): A Look at Phase IV Study Data
Sponsored by Bayer.

“What Was Old Is New Again”: A Novel, More Bioavailable Antifungal
Sponsored by Mayne Pharma.

The Role of Type-2 Inflammation in Asthma and CRSwNP
Sponsored by Sanofi Genzyme and Regeneron.

The Clinical Utility of the BioFire Pneumonia Panel During the COVID-19 Pandemic
Sponsored by BioFire Diagnostics.

Modernized Tetracycline for the Treatment of Adults With CABP and ABSSSI
Sponsored by Paratek Pharmaceuticals.

Rethinking the Role of Nebulization in the Maintenance Treatment of COPD
Sponsored by Mylan Inc. | Theravance Biopharma.

New Advancements in Respiratory Health: From Hospital to Home
Sponsored by Hillrom.

Exploring Idiopathic Pulmonary Fibrosis (IPF) With the Experts
Sponsored by Genentech.

Results of an Expert Consensus Survey on the Treatment of PAH With Oral Prostacyclin Pathway Agents
Sponsored by Actelion Pharmaceuticals US Inc.

Understanding Chronic Cough
Sponsored by Merck.

On-demand prerecorded presentations are available for viewing in the platform until January 2021.

Targeting a Common Contributor to Severe Asthma
Sponsored by AstraZeneca.

Thinking Differently about Asthma Management: Revisiting the Window of Opportunity
Sponsored by AstraZeneca.

TSLP: A Key Epithelial Cytokine at the Top of the Asthma Inflammatory Cascade
Sponsored by AstraZeneca and Amgen.

Improving Lung Cancer and ILD Diagnostic Confidence With Percepta and Envisia Classifiers
Sponsored by Veracyte.

Type 2 Inflammation in Asthma, CRSwNP, NSAID ERD, and COPD
Sponsored by Sanofi Genzyme and Regeneron.

The Role of Type-2 Inflammation in Asthma and CRSwNP
Sponsored by Sanofi Genzyme and Regeneron.

Treatable Traits Approach Towards COPD Management for Busy Pulmonologists
Sponsored by GlaxoSmithKline.

Recognizing Uncontrolled Asthma Is Only the First Step
Sponsored by GlaxoSmithKline.

Chronic Rhinosinusitis, Nasal Polyps, and Asthma: The Unified Airway
Sponsored by GlaxoSmithKline.

Severe Eosinophilic Asthma: Recognition and Management of Co-morbidities
Sponsored by GlaxoSmithKline.

Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma
Sponsored by GlaxoSmithKline.

Clinical Overview of SUNOSI® and a Patient Case Study
Sponsored by Jazz Pharmaceuticals.

Identifying and Managing Patients: The Value of Patient Management, Lung Health Programs, and LungGPS™ Patient Management Platform
Sponsored by Medtronic.

Recognizing Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype: A Focus on Radiology
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

BLVR in the Trenches: High-Volume Community Hospital Perspective
Sponsored by Olympus.

Advances in the Diagnosis & Treatment of PE
Sponsored by Boston Scientific.

Understanding Nasal Polyposis
Sponsored by Novartis Pharmaceuticals Corporation.

*These symposia and learning theater presentations are not supported, endorsed, or accredited by the American College of Chest Physicians.